prednisolone has been researched along with Batten Turner Congenital Myopathy in 2 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| EL-GHOLMI, A | 1 |
| ABOUL-DAHAB, YW | 1 |
| ZAKI, K | 1 |
| Huber, A | 1 |
2 other studies available for prednisolone and Batten Turner Congenital Myopathy
| Article | Year |
|---|---|
SERUM AND MUSCLE POTASSIUM, SODIUM, MAGNESIUM AND CALCIUM IN MYOTONIA CONGENITA.
Topics: Blood; Calcium; Calcium, Dietary; Child; Drug Therapy; Electrocardiography; Electromyography; Humans | 1964 |
[Therapy of oculomotor muscle paralysis].
Topics: Administration, Topical; Anti-Inflammatory Agents; Guanethidine; Humans; Myasthenia Gravis; Myositis | 1968 |